Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

A, Camperdown N Clinical Trials

A listing of A, Camperdown N clinical trials actively recruiting patients volunteers.

RESULTS

Found (3640) clinical trials

This is a single-arm, multi-cohort, multi-center, Phase 2 study to determine the efficacy and safety of JCAR017 in adult subjects with aggressive B-cell NHL. The study will enroll subjects in Europe and Japan with DLBCL NOS (de novo or tFL), high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements …

Phase

The Memory Health Center at Summit Research Network, is enrolling participants in the Clarity AD Research Study.  This research study will evaluate whether an investigational study drug is safe and effective in slowing the progression of Alzheimer’s. Study participation may last to up 23 months with the option to participate …

Phase N/A

The Memory Health Center at Summit Research Network, is enrolling participants in a new mild Alzheimer’s clinical trial. This trial will evaluate the safety and effectiveness of the study medication, azeligaron in the treatment of mild Alzheimer’s disease in patients who also have glucose intolerance or Type 2 Diabetes: those …

Phase

Study participation will last about a year.   Following a screening period of up to 6 weeks, qualified participants will be randomly assigned to the oral investigational medication, C0R388, or a placebo (an inactive substance).   During the treatment period, the participants will visit the research center 9 times over a 48 …

Phase

People who may develop Alzheimer's Disease are asked to participate in a research study being conducted by New York University School of Medicine.

Phase N/A

This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in …

Phase

A research study is evaluating a drug-free investigational capsule for unexplained chronic constipation.  

Phase N/A

This is an open-label, randomized (1:1), multicenter, Phase 3 clinical trial evaluating the safety and efficacy of nivolumab in combination with investigational agent sitravatinib compared to docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with …

Phase